Lois Smith
10Patents
3h-index
11Co-inventors
57Inventor score
Filing activity: Jul 12, 1995 → Oct 27, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5814620A | Inhibition of neovascularization using vegf-specific oligonucleotides | Chemistry; Metallurgy | 129 | Expired |
| US5801156A | Inhibition of neovascularization using VEGF-specific oligonucleotides | Chemistry; Metallurgy | 18 | Expired |
| US5710136A | Inhibition of neovascularization using VEGF-specific oligonucleotides | Chemistry; Metallurgy | 9 | Expired |
| US12415847B2 | ApoM-Fc fusion proteins for treating lung diseases | Chemistry; Metallurgy | 0 | Active |
| US11583528B2 | FFA1 (GPR40) as a therapeutic target for neural angiogenesis diseases or disorders | Physics | 0 | Active |
| US9463222B2 | Methods for treatment of complications of prematurity comprising administration of IGF-I and IGFBP-3 | Human Necessities | 0 | Active |
| US8518877B2 | Method and product for treatment and/or prevention of complications of prematurity | Human Necessities | 0 | Active |
| US7776820B2 | Methods for decreasing risk of complications of prematurity using IGF-I and its analogs | Physics | 0 | Active |
| US7144707B2 | Determination of risk and treatment of complications of prematurity | Physics | 0 | Expired |
| US12298247B2 | Resonance Raman spectroscopy for evaluating mitochondrial function | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.